Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based Monoclonal Antibodies Against Zika Virus
/
Date01 Dec 2016
Grant Provides Funding to Help Prepare New Zika Therapy for Human Trials Inovio Already in Two Human Trials for its Preventive Zika Vaccine PLYMOUTH MEETING, Pa.... Read More →
Anavex Life Sciences to Present at Annual Mental Health Parity Addiction Equity Act Roundtable at U.S. Capitol, Washington, DC
/
Date01 Dec 2016
NEW YORK, Dec. 01, 2016 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today announced that Christopher U. Missling, Ph.D., President... Read More →
Let's get digital: Free download from ACP compiles literature abstracts on latest dental technologies
/
Date01 Dec 2016
CHICAGO, Dec. 1, 2016 (GLOBE NEWSWIRE) — Dentists considering new and highly touted digital technologies might wonder: where’s the evidence? A great place to... Read More →
Kura Oncology Presents Preclinical Data on KO-947 and Menin-MLL Inhibitor Program at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
/
Date01 Dec 2016
LA JOLLA, Calif., Dec. 01, 2016 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company, today presented preclinical data highlighting the identification... Read More →
Cyclacel’s Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential in Esophageal Cancer and Acute Leukemia
/
Date01 Dec 2016
BERKELEY HEIGHTS, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that... Read More →
Positive Pre-Clinical and Clinical Data for Nohla Therapeutics’ Cell Product to Be Presented at the 58th ASH Annual Meeting and Exposition
/
Date01 Dec 2016
SEATTLE, Dec. 01, 2016 (GLOBE NEWSWIRE) — Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with... Read More →
The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function in Patients With Chronic Heart Failure
/
Date30 Nov 2016
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Nov. 30, 2016 (GLOBE NEWSWIRE) — Amgen (NASDAQ:AMGN) and Cytokinetics, Inc. (NASDAQ:CYTK) today announced The Lancet published... Read More →
Seasons Applauds Senator Wyden for Introducing Senate Resolution Designating November as National Hospice and Palliative Care Month
/
Date30 Nov 2016
WASHINGTON, Nov. 30, 2016 (GLOBE NEWSWIRE) — Seasons Hospice & Palliative Care joins the entire hospice and palliative care community in thanking Senator Ron Wyden... Read More →
Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting
/
Date30 Nov 2016
DURHAM, N.C., Nov. 30, 2016 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (Nasdaq:HTBX), a leader in the development of gp96-based immunotherapies that are designed to activate... Read More →
Having the “Gotta Go” Conversation: Get the Facts, Get Diagnosed and Take Control of Your Bladder Health
/
Date30 Nov 2016
NEW YORK, Nov. 30, 2016 (GLOBE NEWSWIRE) — The Urology Care Foundation and the American Urological Association (AUA), together with the Bladder Health Alliance –... Read More →